The aim of our case series was to show the therapeutic effect andthe safety of the use of polidocanol foam in ultrasound-guided sclerotherapy treatment ofrelatively small postoperative seromas after varicose vein surgery.
Methods:
We treated six patients with postoperative seromas after varicose vein surgery that were refractory to conventional treatments including compression dressings, repeated needle aspirations and manual lymph drainage.
Results:
A complete regression of the fluid collections was seen after one and two ultrasound-guided injections of polidocanol foam into the seroma cavity in two cases, respectively. Up to five treatment sessions and up to four further needle aspirations were necessary for the remaining two patients until complete regression of the seromas. No side-effects were reported.
Conclusion:
This is the first case series to report of the regression of postoperative seromas after varicose vein surgery induced by polidocanol foam sclerotherapy.
RabeE, SchliephakeD, OttoJ, BreuFX, PannierF. Sclerotherapy of telangiectases and reticular veins: a double-blind, randomized, comparative clinical trial of polidocanol, sodium tetradecyl sulphate and isotonic saline (EASI study).Phlebology2010; 25: 124–31.
2.
DuffyD. Sclerosants: a comparative review.Dermatol Sur2010; 36: 1010–25.
3.
Hamel-DesnosC, DesnosP, WollmannJC, OuvryP, MakoS, AllaertFA. Evaluation of the efficacy of polidocanol in the form of foam compared with liquid form in sclerotherapy of the greater saphenous vein: initial results.Dermatol Surg2003; 29: 1170–5.
4.
YamakiT, NozakiM, IwasakaS. Comparative study of duplex-guided foam sclerotherapy and duplex-guided liquid sclerotherapy for the treatment of superficial venous insufficiency.Dermatol Surg2004; 30: 718–22.
5.
RabeE, OttoJ, SchliephakeD, PannierF. Efficacy and Safety of Great Saphenous Vein Sclerotherapy Using Standardised Polidocanol Foam (ESAF): a randomised controlled multicentre clinical trial.Eur J Vasc Endovasc Surg2008; 35: 238–45.
6.
Kreussler. Aethoxysklerol-Fachinformation der Herstel-lerfirma Chemische Fabrik Kreussler & Co GmbH, Stand 6/2005, www.kreussler-pharma.de/getmedia.
7.
LaversonS. Polidocanol for refractory seroma.Plast Reconstr Surg1999; 104: 1212.
8.
KlodeJ, KlötgenK, KörberA, SchadendorfD, Disse-mondJ. Polidocanol foam sclerotherapy is a new and effective treatment for post-operative lymphorrhea and lymphocele.J Eur Acad Dermatol Venereol2010; 24: 904–9.
9.
TessariL, CavezziA, FrulliniA. Preliminary experience with a new sclerosing foam in the treatment of varicose veins.Dermatol Surg2001; 27: 58–60.
10.
PartschH, FlourM, SmithPC; International Compression Club. Indications for compression therapy in venous and lymphatic disease consensus based on experimental data and scientific evidence. Under the auspices of the IUP.Int Angiol2008; 27: 193–219.
11.
MoutonW, KellerS, NaefM, WagnerHE. Primary surgery for saphenofemoral incompetence: a randomised controlled trial to compare two techniques to reduce lymphatic complications.VASA2009; 38: 234–7.
12.
OuvryP, GuenneguezH, OuvryPA. Lymphatic complications from variceal surgery.Phlebologie1993; 46: 563–8.
13.
ElvyM. Post ambulatory phlebectomy: chronic peripheral lymphocoele.Phlebology2010; 25: 158–60.
14.
De MaeseneerMG, VandenbroeckCP, LauwersPR, Hen-driksJM, De HertSG, Van SchilPE. Early and late complications of silicone patch saphenoplasty at the saphenofemoral junction.J Vasc Surg2006; 44: 1285–90.
15.
BaierPN, KönigZT, MiszczakHJ. Stark lymphatic complications following an operation on varicose veins by patients with advanced venous insufficience.Phlebologie2008; 37: 227–82.
16.
PittalugaP, ChastanetS. Lymphatic complications after varicose veins surgery: risk factors and how to avoid them.Phlebology2012; 27 (Suppl. 1): 139–42.
17.
DietlB, PfisterK, AufschlägerC, KasprzakPM. Die Strahlentherapie inguinaler Lymphfisteln nach gefäßchirurgischen Eingriffen.Strahlenther Onkol2005; 181: 396–400.
18.
StanczykM, GralaB, ZwierowiczT, MaruszynskiM. Surgical resection for persistent seroma, following modified radical mastectomy.World J Surg Oncol2007; 5: 1–4.
19.
KwaanJHM, BernsteinJM, ConnollyJE. Management of lymph fistula in the groin after arterial reconstruction.Arch Surg1979; 114: 1416–8.
20.
ShermakM, YeeK, WongL, JonesCE, WongJ. Surgical management of groin lymphatic complications after arterial bypass surgery.Plast Reconstr Surg2005; 115: 1954–62.
NeuB, GaussG, HaaseW, DentzJ, HusfeldtKJ. Radiotherapy of lymphatic fistula and lymphocele.Strahlenther Onkol2000; 176: 9–15.
23.
ShihJ, TrerotolaSO, ItkinM. The lymphocele PILL: a case report of Percutaneous Imaging-guided Lymphatic Ligation for the Treatment of Postsurgical Lymph Collections.J Vasc Interv Radiology2008; 19: 1781–4.
24.
ThrockmortonAD, Askegard-GiesmannJ, HoskinTL. Sclerotherapy for the treatment of postmastectomy seroma.Am J Surg2008; 196: 541–4.
25.
MahrerA, RamchandaniP, TrerotolaSO, Shlansky-GoldbergRD, ItkinM. Sclerotherapy in the management of postoperative lymphocele.J Vasc Interv Radiol2010; 21: 1050–3.
26.
ZuckermanDA, YeagerTD. Percutaneous ethanol sclerotherapy of postoperative lymphoceles.AJR Am J Roentgenol1997; 169: 433–7.
27.
CaliendoMVLD, QueirozR, WaldmanDL. Sclerotherapy with use of doxycycline after percutaneous drainage of postoperative lymphoceles.J Vasc Interv Radiol2001; 12: 73–7.
28.
Ali-KhanAS, OrlandoA, KenealyJ. Erythromycin sclerotherapy in the management of seroma.J Plast Reconstr Aesthetic Surg2009; 62: e55–e8.
SilasAM, ForauerAR, PerrichKD, GemeryJM. Sclerosis of postoperative lymphoceles: avoidance of prolonged catheter drainage with use of a fibrin sealant.J Vasc Interv Radiol2006; 17: 1791–5.
31.
ChinA, RagavendraN, HilborneL, GritschHA. Fibrin sealant sclerotherapy for treatment of lymphoceles following renal transplantation.J Urol2003; 170: 380–3.
32.
RohJ-L, ParkCI. OK-432 sclerotherapy of cervical chylous lymphocele after neck dissection.Laryngoscope2008; 118: 999–1002.
33.
GilletJL, GuedesJM, GuexJJ. Side-effects and complications of foam sclerotherapy of the great and small saphenous veins: a controlled multicentre prospective study including 1025 patients.Phlebology2009; 24: 131–8.
